Tamoxifen Resistance: Emerging Molecular Targets
The amino acid sequence is in the public domain and there is no composition-of-matter patent worth pursuing, so no commercial sponsor will fund the hundreds of millions a Phase IIIII development programme costs for a compound it cannot exclusively monetise
[PMID: 6628446] PubMed record related to this compound for laboratory literature review
Retrieved January 30, 2022, from Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW
2a), and time of the reaction from 1 to 30 min (Fig
Rarely, hypersensitivity reactions can occur, for instance, urticaria (hives) or other allergic-type reactions have been reported in isolated cases